Skip to main content
ARTIVION, INC. logo

ARTIVION, INC. — Investor Relations & Filings

Ticker · AORT ISIN · US2289031005 LEI · 549300YTKV8DMSMG6K81 US Manufacturing
Filings indexed 1,531 across all filing types
Latest filing 2022-11-10 Director's Dealing
Country US United States of America
Listing US AORT

About ARTIVION, INC.

https://artivion.com/

Artivion, Inc. is a medical device company focused on developing, manufacturing, and distributing solutions for cardiac and vascular surgery. The company has an intentional focus on creating technologies to treat diseases of the aorta. In collaboration with surgeons, Artivion develops products designed to address complex surgical challenges. Its portfolio includes a range of aortic-centric technologies, such as heart valve solutions, implantable human tissues (allografts), surgical sealants, and various stent grafts for the aortic arch, thoracoabdominal, abdominal, and peripheral aorta. The company's purpose is to provide simple, elegant solutions that improve surgical outcomes for patients with aortic diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-11-10 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the departure and appointment of directors or officers and the granting of equity awards to executive officers. This fits the category of Board/Management Information (MANG), as it announces changes and compensatory arrangements related to senior management. The document is not an annual or quarterly report, earnings release, or other financial report type. It is not a proxy statement or voting result announcement. Therefore, the appropriate classification is MANG with high confidence.
2022-11-09 English
FORM 4
Director's Dealing
2022-11-07 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 3, 2022, for Artivion, Inc. It specifically mentions Item 2.02 "Results of Operations and Financial Condition" and includes a press release announcing financial results for the third quarter ended September 30, 2022. The document states that the press release is attached as Exhibit 99.1 and is "furnished" but not "filed." The content is a current report providing an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). The document is about 5267 characters, which is consistent with a typical 8-K earnings release filing. Therefore, the classification is Earnings Release (ER).
2022-11-03 English
FORM 3
Director's Dealing
2022-10-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.